Citigroup Inc I Teos Therapeutics, Inc. Transaction History

Citigroup Inc

$196 Billion
Q2 2025

A detailed history of Citigroup Inc transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 39,742 shares of ITOS stock, worth $403,381. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,742

Previous 19,184 107.16%

Holding current value

$403,381

Previous $114,000 247.37%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$5.04 - $10.2 $103,612 - $209,691	20,558 Added 107.16%	39,742 $396,000
Q1 2025 May 12, 2025	SELL	$5.97 - $8.15 $4.98 Million - $6.8 Million	-834,597 Reduced 97.75%	19,184 $114,000
Q4 2024 Feb 12, 2025	BUY	$7.22 - $10.02 $6.02 Million - $8.35 Million	833,589 Added 4128.31%	853,781 $6.56 Million
Q3 2024 Nov 12, 2024	BUY	$10.09 - $17.97 $85,734 - $152,691	8,497 Added 72.65%	20,192 $206,000
Q2 2024 Aug 12, 2024	SELL	$10.33 - $18.09 $2.94 Million - $5.14 Million	-284,289 Reduced 96.05%	11,695 $173,000
Q1 2024 May 10, 2024	SELL	$9.89 - $13.64 $482,810 - $665,877	-48,818 Reduced 14.16%	295,984 $4.04 Million
Q4 2023 Feb 09, 2024	BUY	$8.57 - $11.06 $2.22 Million - $2.86 Million	258,468 Added 299.38%	344,802 $3.78 Million
Q3 2023 Nov 09, 2023	SELL	$10.95 - $14.6 $1.62 Million - $2.17 Million	-148,333 Reduced 63.21%	86,334 $945,000
Q2 2023 Aug 10, 2023	SELL	$12.93 - $18.05 $701,038 - $978,634	-54,218 Reduced 18.77%	234,667 $3.11 Million
Q1 2023 May 11, 2023	BUY	$13.02 - $22.62 $710,748 - $1.23 Million	54,589 Added 23.3%	288,885 $3.93 Million
Q4 2022 Feb 09, 2023	SELL	$17.77 - $21.6 $1.07 Million - $1.3 Million	-59,957 Reduced 20.38%	234,296 $4.58 Million
Q3 2022 Nov 10, 2022	BUY	$18.6 - $27.25 $3.14 Million - $4.59 Million	168,551 Added 134.09%	294,253 $5.61 Million
Q2 2022 Aug 10, 2022	BUY	$16.57 - $35.1 $1.55 Million - $3.28 Million	93,349 Added 288.53%	125,702 $2.59 Million
Q1 2022 May 12, 2022	SELL	$31.92 - $47.45 $5.62 Million - $8.36 Million	-176,147 Reduced 84.48%	32,353 $1.04 Million
Q4 2021 Feb 10, 2022	SELL	$26.23 - $47.86 $5.38 Million - $9.81 Million	-204,972 Reduced 49.57%	208,500 $9.71 Million
Q3 2021 Nov 10, 2021	BUY	$23.91 - $29.58 $9.89 Million - $12.2 Million	413,472 New	413,472 $11.2 Million

Others Institutions Holding ITOS

# of Institutions

120

Shares Held

33.7M

Call Options Held

733K

Put Options Held

611K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $361M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account